Technical analysis of Quince Therapeutics, Inc. (QNCX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites.
Price
| Price | $27.17 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.43 |
| EV / EBITDA | 1.48 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 14.52 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -8.15 |
Explore sector: Healthcare · Biotechnology
More sections of QNCX: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks